Chlorhexidine Gluconate (CHG) Wipes Global Market Report 2024

The chlorhexidine gluconate (chg) wipe market size has grown strongly in recent years. It will grow from $47.4 billion in 2023 to $49.92 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth observed in the historical period can be attributed to concerns related to healthcare-associated infections (HAIs), efforts to prevent surgical site infections (SSIs), regulatory endorsements supporting infection control measures, a surge in hospital admissions, and an increase in the prevalence of chronic diseases.

The chlorhexidine gluconate (chg) wipe market size is expected to see strong growth in the next few years. It will grow to $61.46 billion in 2028 at a compound annual growth rate (CAGR) of 5.3%. The anticipated growth in the forecast period can be attributed to hygiene measures driven by the pandemic, a growing elderly population, the global expansion of healthcare facilities, increased consumer awareness and demand, and government initiatives emphasizing infection control. Key trends in the forecast period encompass the development of environmentally friendly formulations, advanced packaging designs, innovations in wipe textures, the integration of telemedicine and remote care solutions, and a heightened focus on over-the-counter (OTC) and retail markets.

The escalation in surgical procedures is poised to significantly influence the growth trajectory of the chlorhexidine gluconate (CHG) wipes market. Surgical procedures entail interventions that involve incisions and specific tools aimed at treating diseases within a living organism. Utilized across diverse surgical contexts, chlorhexidine gluconate (CHG) wipes play a pivotal role in eradicating potentially harmful microbes from the skin and curbing further microbial proliferation. For instance, data from the Aesthetic Society in April 2022 highlighted that the average plastic surgeon performed 320 surgical operations, a notable increase from 220 surgeries conducted in 2020. Furthermore, there was a substantial surge of 54% in surgical procedures for plastic and cosmetic surgeries in 2021. Consequently, the burgeoning volume of surgical procedures remains a primary driver for the chlorhexidine gluconate (CHG) wipes market's growth.

The growth of the chlorhexidine gluconate (CHG) wipes market is anticipated to be propelled by the mounting incidence of healthcare-associated infections (HAIs). Healthcare-associated infections (HAIs) denote infections contracted by individuals during their healthcare treatment within hospital, clinic, or similar settings. Chlorhexidine gluconate (CHG) wipes play a pivotal role in mitigating the risk of healthcare-associated infections (HAIs) by offering effective antiseptic skin preparation in medical environments. For example, a report published by the World Health Organization (WHO) in May 2022 highlighted alarming statistics, more than 24% of patients afflicted by healthcare-associated sepsis and 52.3% of those treated in intensive care units succumb to the condition annually. The risk of mortality significantly amplifies when infections exhibit resistance to antimicrobial treatments. In acute-care hospitals, an estimated 7 out of every 100 patients in high-income countries and 15 out of every 100 patients in low- and middle-income countries are expected to acquire at least one healthcare-associated infection (HAI) during their hospital stay. Hence, the surge in healthcare-associated infections (HAIs) is anticipated to be a driving force behind the chlorhexidine gluconate (CHG) wipes market's growth trajectory.

Product innovation is a prominent trend shaping the chlorhexidine gluconate (CHG) wipes market, with major players focusing efforts on pioneering new products to solidify their market presence. An illustration of this trend is evident in the introduction of Super Sani-Cloth wipes by PDI Healthcare in June 2021. These wipes, available in soft packs, offer heightened versatility with minimal environmental impact. Widely incorporated in meticulous environmental hygiene and infection control programs, these wipes serve as a comprehensive cleaner and disinfectant, boasting impressive kill times of 60 seconds against 44 healthcare-specific pathogens, including a 45-second Mycobacterium bovis (TB) claim.

Significant companies operating in the chlorhexidine gluconate (CHG) wipes market are intensifying their focus on developing innovative products, such as antiseptic solutions, to expand their product portfolios and cater to the escalating demand for effective and adaptable antiseptic solutions. Notably, in June 2023, HR Pharmaceuticals, Inc. unveiled CliniClean Chlorhexidine Gluconate (CHG) 4%, an antiseptic solution tailored to provide comprehensive skin protection against a diverse range of microorganisms, effectively reducing the risks associated with healthcare-associated and surgical site infections. This versatile antiseptic/antimicrobial solution is adeptly designed for various applications including patient pre-operative preparation, surgical hand scrubs, healthcare personnel handwashing, as well as general skin and wound cleansing. The clinical efficacy of CliniClean is evident in its ability to substantially diminish skin bacteria through repeated use, ensuring prolonged germ-fighting efficacy even after application.

In September 2022, Schülke & Mayr GmbH, a Germany-based healthcare company, successfully acquired Vesismin Health for an undisclosed amount. This strategic acquisition served to enhance Schülke & Mayr's product portfolio in infection prevention and hygiene solutions. Vesismin Health, based in Spain, is a manufacturer specializing in infection prevention and hospital disinfection products, including Chlorhexidine Gluconate (CHG) wipes and Chlorhexidine Antiseptic.


Major companies operating in the chlorhexidine gluconate (chg) wipes market report are Cardinal Health Inc., 3M Co, Johnson & Johnson MedTech, McKesson Medical-Surgical Inc., Medline Industries Inc., Becton Dickinson and Company, Stryker Corporation, Ecolab Inc., Smith & Nephew Plc., Ethicon Inc., Coloplast AS, Purdue Products L.P, Owens & Minor Inc., Pal International, Molnlycke Health Care AB, Halyard Health Inc., ICU Medical Inc., Nice-Pak Products Inc., Sage Products LLC, ConvaTec Group PLC, GAMA Healthcare Ltd., Dynarex-Corporation, AvaCare Medical LLC, PDI Ltd., Lernapharm Inc., Carenow Medical Pvt. Ltd., Clinicept Healthcare Ltd.

North America was the largest region in the chlorhexidine gluconate (CHG) wipes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chlorhexidine gluconate (chg) wipes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chlorhexidine gluconate (chg) wipes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

There are two main types of CHG wipes such as chlorhexidine gluconate (CHG) bath wipes and chlorhexidine gluconate (CHG) alcohol-based wipes. CHG bath wipes are disposable antiseptic cloths that facilitate bathing for hospital patients without the need for rinsing. They are utilized to cleanse the skin and prevent infections. Applications for these wipes include addressing surgical site infections, central line-associated bloodstream infections, catheter-associated urinary tract infections, and other related conditions. Distribution channels for CHG wipes encompass pharmacies, supermarkets, specialty stores, and direct sales channels, catering to a wide range of healthcare facilities such as hospitals, clinics, ambulatory surgical centers, among others.

The chlorhexidine gluconate (CHG) wipes research report is one of a series of new reports that provides chlorhexidine gluconate (CHG) wipes market statistics, including the chlorhexidine gluconate (CHG) wipes industry's global market size, regional shares, competitors with chlorhexidine gluconate (CHG) wipes market share, detailed chlorhexidine gluconate (CHG) wipes market segments, market trends and opportunities, and any further data you may need to thrive in the chlorhexidine gluconate (CHG) wipes industry. This chlorhexidine gluconate (CHG) wipes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chlorhexidine gluconate (CHG) wipes market consists of sales of skin antiseptic wipes, pre-surgery wash sponges, and surgical skin disinfectants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.